P. Cohort, ). , and C. Torti, Myriam Garrido (VACH); European AIDS Treatment Group: Nikos Dedes; Project Leaders: Caroline Sabin, COHERE data managers Nikos Pantazis (AMACS), Jérôme Lechenadec (ANRS CO1/CO10 EPF)

D. Maso, L. Franceschi, and S. , Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS, The Lancet Oncology, vol.4, issue.2, pp.110-119, 2003.
DOI : 10.1016/S1470-2045(03)00983-5

M. Frisch, R. Biggar, E. Engels, and J. Goedert, Association of Cancer With AIDS-Related Immunosuppression in Adults, JAMA, vol.285, issue.13, pp.1736-1745, 2001.
DOI : 10.1001/jama.285.13.1736

T. Cote, R. Biggar, and P. Rosenberg, Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden, International Journal of Cancer, vol.311, issue.5, pp.645-650, 1997.
DOI : 10.1002/(SICI)1097-0215(19971127)73:5<645::AID-IJC6>3.0.CO;2-X

B. Ledergerber, M. Egger, and V. Erard, AIDS-Related Opportunistic Illnesses Occurring After Initiation of Potent Antiretroviral Therapy, JAMA, vol.282, issue.23, pp.2220-2226, 1999.
DOI : 10.1001/jama.282.23.2220

E. Engels, R. Biggar, and H. Hall, Cancer risk in people infected with human immunodeficiency virus in the United States, International Journal of Cancer, vol.132, issue.1, pp.187-194, 2008.
DOI : 10.1002/ijc.23487

N. Crum-cianflone, K. Hullsiek, and V. Marconi, Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study, AIDS, vol.23, issue.1, pp.41-50, 2009.
DOI : 10.1097/QAD.0b013e328317cc2d

J. Long, E. Engels, R. Moore, and K. Gebo, Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals, AIDS, vol.22, issue.4, pp.489-496, 2008.
DOI : 10.1097/QAD.0b013e3282f47082

M. Arminio, C. Sabin, and A. Phillips, The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy, Arch Intern Med, vol.165, pp.416-423, 2005.

J. Spano, D. Costagliola, C. Katlama, N. Mounier, E. Oksenhendler et al., AIDS-Related Malignancies: State of the Art and Therapeutic Challenges, Journal of Clinical Oncology, vol.26, issue.29, pp.4834-4842, 2008.
DOI : 10.1200/JCO.2008.16.8252

F. Bonnet, C. Burty, and C. Lewden, Changes in Cancer Mortality among HIV???Infected Patients: The Mortalit?? 2005 Survey, Clinical Infectious Diseases, vol.48, issue.5, pp.633-639, 2005.
DOI : 10.1086/596766

O. Kirk, C. Pedersen, and A. Cozzi-lepri, Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy, Blood, vol.98, issue.12, pp.3406-3412, 2001.
DOI : 10.1182/blood.V98.12.3406

J. Stebbing, B. Gazzard, and S. Mandalia, Antiretroviral Treatment Regimens and Immune Parameters in the Prevention of Systemic AIDS-Related Non-Hodgkin's Lymphoma, Journal of Clinical Oncology, vol.22, issue.11, pp.2177-2183, 2004.
DOI : 10.1200/JCO.2004.11.097

J. Polesel, G. Clifford, and M. Rickenbach, Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy, AIDS, vol.22, issue.2, pp.301-306, 2008.
DOI : 10.1097/QAD.0b013e3282f2705d

A. Zoufaly, H. Stellbrink, and M. Der-heide, Insufficient Virus Suppression during HAART Is a Strong Predictor for the Development of AIDS-related Lymphoma, 2008.

R. Biggar, A. Chaturvedi, J. Goedert, and E. Engels, AIDS-Related Cancer and Severity of Immunosuppression in Persons With AIDS, JNCI Journal of the National Cancer Institute, vol.99, issue.12, pp.962-972, 2007.
DOI : 10.1093/jnci/djm010

J. Kjaer and B. Ledergerber, HIV cohort collaborations: proposal for harmonization of data exchange, Antivir Ther, vol.9, pp.631-633, 2004.

E. Engels, P. Rosenberg, M. Frisch, and J. Goedert, Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma, British Journal of Cancer, vol.93, issue.9, pp.1298-1303, 2001.
DOI : 10.1054/bjoc.2001.2052

S. Deloose, L. Smit, F. Pals, M. Kersten, C. Van-noesel et al., High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma, Leukemia, vol.284, issue.5, pp.851-855, 2005.
DOI : 10.1038/sj.leu.2403709

A. Chadburn, E. Hyjek, S. Mathew, E. Cesarman, J. Said et al., KSHV-Positive Solid Lymphomas Represent an Extra-Cavitary Variant of Primary Effusion Lymphoma, The American Journal of Surgical Pathology, vol.28, issue.11, pp.1401-1416, 2004.
DOI : 10.1097/01.pas.0000138177.10829.5c

F. Bonnet, E. Balestre, and R. Thiebaut, Factors Associated with the Occurrence of AIDS-Related Non-Hodgkin Lymphoma in the Era of Highly Active Antiretroviral Therapy: Aquitaine Cohort, France, Clinical Infectious Diseases, vol.42, issue.3, pp.411-417, 2006.
DOI : 10.1086/499054

C. Hoffmann, E. Wolf, and G. Fatkenheuer, Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma, AIDS, vol.17, issue.10, pp.1521-1529, 2003.
DOI : 10.1097/00002030-200307040-00013

A. Antinori, A. Cingolani, and L. Alba, Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy, AIDS, vol.15, issue.12, pp.1483-1491, 2001.
DOI : 10.1097/00002030-200108170-00005

M. Simcock, M. Blasko, and U. Karrer, Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study, Antivir Ther, vol.12, pp.931-939, 2007.

F. Boue, J. Gabarre, and C. Gisselbrecht, Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin's Lymphoma, Journal of Clinical Oncology, vol.24, issue.25, pp.4123-4128, 2006.
DOI : 10.1200/JCO.2005.05.4684

A. Grulich, X. Wan, and M. Law, B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS, AIDS, vol.14, issue.2, pp.133-140, 2000.
DOI : 10.1097/00002030-200001280-00008

S. Lim and A. Levine, Recent Advances in Acquired Immunodeficiency Syndrome (AIDS)-related Lymphoma, CA: A Cancer Journal for Clinicians, vol.55, issue.4, pp.229-241, 2005.
DOI : 10.3322/canjclin.55.4.229

R. Sullivan, L. Pantanowitz, C. Casper, J. Stebbing, and B. Dezube, HIV/AIDS: Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma???Associated Herpesvirus Disease: Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease, Clinical Infectious Diseases, vol.47, issue.9, pp.1209-1215, 2008.
DOI : 10.1086/592298

A. Carbone, E. Cesarman, M. Spina, A. Gloghini, and T. Schulz, HIV-associated lymphomas and gamma-herpesviruses, Blood, vol.113, issue.6, 2008.
DOI : 10.1182/blood-2008-09-180315

M. Du, C. Bacon, and P. Isaacson, Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders, Journal of Clinical Pathology, vol.60, issue.12, pp.1350-1357, 2007.
DOI : 10.1136/jcp.2007.047969
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095558

E. Oksenhendler, E. Boulanger, and L. Galicier, High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease, Blood, vol.99, issue.7, pp.2331-2236, 2002.
DOI : 10.1182/blood.V99.7.2331

Y. Chang, E. Cesarman, and M. Pessin, Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma, Science, vol.266, issue.5192, pp.1865-1869, 1994.
DOI : 10.1126/science.7997879

E. Cesarman, Y. Chang, P. Moore, J. Said, and D. Knowles, Kaposi's Sarcoma???Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity???Based Lymphomas, New England Journal of Medicine, vol.332, issue.18, pp.1186-1191, 1995.
DOI : 10.1056/NEJM199505043321802

H. Hjalgrim and E. Engels, Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence, Journal of Internal Medicine, vol.118, issue.6, pp.537-548, 2008.
DOI : 10.1111/j.1365-2796.2008.02031.x

A. Ridolfo, S. Santambrogio, and F. Mainini, High frequency of non-Hodgkin??s lymphoma in patients with HIV-associated Kaposi??s sarcoma, AIDS, vol.10, issue.2, pp.181-185, 1996.
DOI : 10.1097/00002030-199602000-00008

R. Biggar, R. Curtis, T. Cote, C. Rabkin, and M. Melbye, Risk of Other Cancers following Kaposi's Sarcoma: Relation to Acquired Immunodeficiency Syndrome, American Journal of Epidemiology, vol.139, issue.4
DOI : 10.1093/oxfordjournals.aje.a117008

E. Engels, S. Pittaluga, and D. Whitby, Immunoblastic Lymphoma in Persons with AIDS-Associated Kaposi???s Sarcoma: a Role for Kaposi???s Sarcoma???Associated Herpesvirus, Modern Pathology, vol.16, issue.5, pp.424-429, 2003.
DOI : 10.1097/01.MP.0000056629.62148.55

L. Martin-carbonero, R. Palacios, and E. Valencia, Long???Term Prognosis of HIV???Infected Patients with Kaposi Sarcoma Treated with Pegylated Liposomal Doxorubicin, Clinical Infectious Diseases, vol.47, issue.3, pp.410-417, 2008.
DOI : 10.1086/589865

B. Krishnan and G. Morgan, Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy, Cancer Epidemiology Biomarkers & Prevention, vol.16, issue.3, pp.377-380, 2007.
DOI : 10.1158/1055-9965.EPI-06-1069

M. Silverberg, J. Neuhaus, and M. Bower, Risk of cancers during interrupted antiretroviral therapy in the SMART study, AIDS, vol.21, issue.14, pp.1957-1963, 2007.
DOI : 10.1097/QAD.0b013e3282ed6338

S. Hammer, J. Eron, J. Reiss, and P. , Antiretroviral Treatment of Adult HIV Infection, JAMA, vol.300, issue.5, pp.555-570, 2008.
DOI : 10.1001/jama.300.5.555